The Importance Of Redundancy Aid Learning In Research

The HPV vaccine reception has been similar to that of the hepatitis vaccine in that both are seen as an attack on morality, and are considered by some as a license for promiscuity. In the book Vaccine Allen quotes, ‘ “ If a 10- or 12-year-old is given a vaccine to protect against a sexually transmitted disease, then it’s implied they’d be engaging in risky sexual behavior,” said Pia de Solenni, director of “life and women’s issues” for the Family Research Council’ (433). The fact that HPV lives in the sexual organs and is spread by sexual intercourse or intravenous drug use has caused many parents to come to the belief that their children are not at risk. Some parents go so far as to suggest that if

Using the HPV vaccine as a primary preventive measure to reduce cervical cancer is promising, but the vaccine continues to be underused. One population where there is a significant delay in HPV vaccination use is Adolescents. Many parents tend to believe that their children are not sexually active so they do not recognize the need of vaccination. It is the responsibility of every APN to educate both the parent and the adolescent regarding the importance of administering the vaccine even before the exposure to the infection, similar to other childhood vaccinations. (Daley,Alison)

Single-variable research can answer exciting and important questions like the one in this research, but it does not answer questions about statistical relationships between variables (Jhangiani et al., 2015). Descriptive statistics refers to a set of techniques for summarizing and displaying data (Jhangiani et al., 2015). The study location is within the United States and its territories. The timeline of the study ranges from 2010 – 2015. The logic behind the time is tied to the fact that in 2011, the ACIP endorsed administering the HPV vaccine for adolescent boys with a goal to cover 80% of males aged 13 – 15 years. Therefore, the time frame covers one year before implementation and four years after. There are no anticipated costs associated with this research.

Vanderpool et al. focused on whether or not a free voucher, after a brief interview assessing a few HPV related health risks, would persuade women to receive the full dose of the vaccine. It was found that less than 50% of the women that were presented with a free vaccine voucher redeemed it. The variables that were found to significantly predict uptake in a controlled analysis include “in general vaccines are a good thing” - which displayed that women were about 35% less likely to decline the free vaccine voucher - and “I believe that getting the vaccine will be painful,” which showed that women were approximately 27% less likely to decline the free vaccine voucher. The following three variables were not in a controlled analysis but still

What if a young girl cannot afford or choice not to get the vaccine what is the outcome for them, and then if girls get the vaccine can it really stop young girls from getting Cervical cancer. Adams discuss that “ Cervical Cancer is prevented in a hundred other ways, including adequate sunlight exposure and vitamin D consumption, supplementation with probiotics, adequate intake of selenium and zinc, increased consumption of trace minerals and iodine, regular physical exercise and many other safe, natural, non-patented strategies” (447). Does anyone know really if the HPV vaccine will really stop the profit of cervical cancer? The Center of Disease control and Prevention: reported that the number of new cases has fallen to about 50,000 in 2005 according to Morbidity and Mortality Weekly report of March 16 (449). Allen points out that the women who did receive the vaccine had no major side effects. In other case Cervical Cancer strikes 14,000 American women each year killing one-fourth of them (449). If a young girl, a parent doesn’t want their daughter to get the vaccine or even has second thought about it, they should make a doctor appointment yearly to check for Cervical cancer. Then the next thing to do if the young lady does need the HPV vaccine is learn more about the vaccine and decided if they want to go in that direction for their daughter.

While personal choice concerns to those who oppose the HPV vaccine, promiscuity concerns them the most. Many parents, women support groups, and religious leaders worry that mandating the vaccine will give teenagers one less reason to abstain from sexual activities. The

In an online survey, the survey administrator and his team asked over fifteen hundred parents of 11-17 year old children whether they agreed that laws requiring HPV vaccination for sixth grade school entry were “a good idea” about half of the parent believed the HPV vaccine, was at least as important as the Tdap and Meningococcal vaccines, the other two recommended for adolescent, only forty percent believed the vaccine prevented cervical cancer. Nearly a quarter of the parents inaccurately believed the vaccine might cause long term health problems and one

HPV vaccinations have been involved in some heated debates involving the general public and the government for some time now; whether the vaccine is worth being administered to young girls is the underlying question and if so at what cost. In the articles “HPV Vaccine Texas Tyranny” and “The HPV Debate” both authors Mike Adams and Arthur Allen provide enlightening information on why the HPV vaccinations should not be mandated through legislation, Adams conveys his bias and explains how the government is over stepping its boundaries when it comes to the publics’ health while Allen on the other hand, is more opt to present analytical data on previous cases similar to the one he is currently facing.

After reading the article about the human papillomavirus (HPV), my curiosity spiked. As a mother of 2 girls, I will have to decide soon if the HPV vaccine is one I want my children to receive. I have head multiple arguments for and against the HPV vaccine, but have done little research on my own. As always, it is amazing how many questions can be answered and cleared by a few hours of research and self-education. Some of the amazing facts gathered include the discovery that it only takes one infected sexual partner in an entire lifetime to contract the HPV virus, 80% of sexually active people will contract the disease while experiencing no symptoms, and the virus is contracted via skin to skin contact making it very infectious.

Also, the ability to offer the HPV vaccine at the time of the HPV educational presentation may have increased HPV vaccination rates. The college-aged male athletes indicated an overall increase in the intention to obtain the HPV vaccine, however the actual HPV vaccination rate only increased by 8%. If the HPV vaccine had been readily available at the time of the HPV presentation, the college-aged male athletes may have been more apt to act upon their intention to obtain the HPV vaccine.

Sociocultural issues with this vaccine include uneducated patients whom do not understand the relationship between HPV and cervical cancer. It is imperative to educate patients on this relationship. Education on the benefits of the vaccine with proven evidence of decrease incidences of HPV infections and the decrease in the occurrence of cervical cancer.

Between 2007 and 2009, an HPV vaccine program was introduced in Australia. Three years after the introduction, Brotheron, Fridman, May, Chappell, Saville, and Gertig (2011) examined how these vaccines affected women’s cervical health. It was found that after the vaccine program was introduced, there was a lower number of reports of women having high-grade cervical abnormalities. While this was only the first report, it shows great promise that implementing a program for the HPV vaccine will have a positive effect on women’s health. The lower the chances are for people to contract the HPV virus means that there’s a lower chance that people will develop cervical cancer and other

There have been concerns about the safety of the HPV vaccines. In Basu’s (2013) article they reviewed the evidence from the phase III trials and national programs for the HPV vaccine. After reviewing the data though the article showed that all the randomized control trials reported both their serious and non-serious adverse events that took place during the phase III trials. “There were 20,000 participants in the trial” (p.4). Pain at the injection site, headache, and fatigue were the most frequently reported issues. The serious adverse effects were very rare so the vaccine was considered safe.

The Human Papillomavirus (HPV), a sexually transmitted disease (STD), is the most common sexually transmitted disease in the United States with about 14 million cases each year. There are two different types of HPV: low-risk and high-risk. According to the Centers for Disease Control and Prevention (CDC), “more than 90 percent and 80 percent, respectively, of sexually active men and women will be infected with at least one type of HPV at some point in their lives. Around one-half of these infections are with a high-risk HPV” (CDC n.p.). High-risk HPV can sometimes cause cancer; however, there is no way of predicting which infected persons could develop cancer or other serious health problems. The most common form of HPV, low-risk, causes warts; this type of HPV goes away on its own in most cases (CDC n.p.). A vaccination, proven to prevent against four major stands of HPV, has recently been developed. The vaccination has led to an enormous amount of controversy regarding whether the vaccination should be mandatory. Although the vaccine is new, it has been proven effective in preventing HPV and numerous types of cancer caused by HPV; therefore, it should be mandatory in order to protect today’s youth from HPV.

Table 4. They found no difference in HPV vaccination intention between the experimental and control conditions. Intervention 5.9 +3.1 control: 5.7 + 2.7, with